| P2093 | author name string | Tracey KJ | |
| | Dautry F | |
| | Cavaillon JM | |
| | Fitting C | |
| | Amiot F | |
| P2860 | cites work | Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis | Q72651297 |
| | Abnormal organisation of the splenic marginal zone and the correlated leukocytosis in lymphotoxin-alpha and tumor necrosis factor alpha double deficient mice | Q73017940 |
| | Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage | Q73296033 |
| | MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia | Q28265011 |
| | Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 |
| | Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection | Q28509078 |
| | Characterization of tumor necrosis factor-deficient mice | Q28512785 |
| | Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes | Q28593744 |
| | Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice | Q28593915 |
| | Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine | Q33356537 |
| | Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo | Q34146304 |
| | Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia | Q34173960 |
| | An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality | Q34367944 |
| | CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. | Q34380078 |
| | Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone | Q34381322 |
| | Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. | Q34521810 |
| | Role of interleukin-1 in the pathogenesis of experimental shigellosis | Q35752669 |
| | Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture. | Q35833222 |
| | Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor | Q36352519 |
| | Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma | Q36356469 |
| | Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia | Q36357020 |
| | Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents | Q36361007 |
| | Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia | Q36362194 |
| | Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival | Q36966855 |
| | Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo | Q37031936 |
| | Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. | Q37608027 |
| | Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin | Q37629829 |
| | Involvement of a nuclear factor-kappa B-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor. | Q38332893 |
| | Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice | Q40150849 |
| | Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever | Q40766621 |
| | Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model | Q41099276 |
| | Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies | Q41113572 |
| | Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin | Q41325387 |
| | Down-regulation of IL-1 beta biosynthesis by inducers of the heat-shock response | Q41390761 |
| | Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor | Q41447978 |
| | Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody | Q42015280 |
| | Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees | Q42942649 |
| | Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity | Q43462496 |
| | Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells | Q43546822 |
| | IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha | Q43715420 |
| | Effect of anti-TNF-alpha treatment in an antibiotic treated murine model of shock due to Streptococcus pyogenes | Q43844247 |
| | Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys | Q44270287 |
| | Production of tumor necrosis factor-alpha and interleukin-6 in mice infected with group B streptococci | Q46423366 |
| | Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. | Q46683778 |
| | Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections | Q48002147 |
| | Lipopolysaccharide‐induced interleukin‐10 in mice: role of endogenous tumor necrosis factor‐α | Q50142242 |
| | Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. | Q52846790 |
| | IL-2 induces IL-6 production in human monocytes. | Q53492450 |
| | Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. | Q53753081 |
| | Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors. | Q54616210 |
| | Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. | Q54693548 |
| | Detection of circulating tumor necrosis factor after endotoxin administration. | Q54747335 |
| | Interleukin-1 receptor antagonist reduces mortality from endotoxin shock | Q59092106 |
| | PEG-BP-30 Monotherapy Attenuates the Cytokine-Mediated Inflammatory Cascade in Baboon Escherichia coli Septic Shock | Q62104495 |
| | Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-chi B and NF-IL6 | Q67504299 |
| | Platelet-activating factor enhances interleukin-6 production by alveolar macrophages | Q67506279 |
| | Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha | Q68020403 |
| | Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality | Q68260492 |
| | Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists | Q70466614 |
| | Interferon-gamma inhibits interleukin-8 production by human polymorphonuclear leucocytes | Q70659464 |
| | The production of TNF alpha and IL-8 in whole blood assays are differently regulated upon activation by LPS | Q70795279 |
| | Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: beneficial effects in sepsis syndrome | Q70946386 |
| | Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group | Q71094855 |
| | Endotoxin-induced release of interleukin 6 and interleukin 1 beta in human blood is independent of tumor necrosis factor alpha | Q71193768 |
| | Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production | Q71620199 |
| | Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration | Q71829134 |
| | Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes | Q71938372 |
| | Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice | Q72515441 |
| | Protective effect of an adenosine kinase inhibitor in septic shock | Q72526859 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipopolysaccharide | Q421804 |
| | TNF | Q18032037 |
| P304 | page(s) | 864-875 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice | |
| P478 | volume | 3 | |